#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	518	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c4.ctg.1	907	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(2')-Ic;b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis."
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	C69T	SNP	69	69	C	278	278	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	G72.	DEL	72	72	G	280	280	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	T74.	DEL	74	74	T	281	281	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	T77C	SNP	77	77	T	284	284	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	G81A	SNP	81	81	G	287	287	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	T84C	SNP	84	84	T	290	290	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	72	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c4.ctg.1	326	0.0	0	.	n	.	0	G85A	SNP	85	85	G	291	291	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	434	Erm_37_	540	540	100.0	Erm_37_.l15.c30.ctg.1	1293	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Erm(37);b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.'
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T8C	SNP	8	8	T	30	30	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	A96G	SNP	96	96	A	118	118	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T98G	SNP	98	98	T	120	120	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T146C	SNP	146	146	T	168	168	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	A217G	SNP	217	217	A	239	239	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T238C	SNP	238	238	T	260	260	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	A261G	SNP	261	261	A	283	283	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	C263A	SNP	263	263	C	285	285	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	G265A	SNP	265	265	G	287	287	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	A280C	SNP	280	280	A	302	302	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	A285T	SNP	285	285	A	307	307	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T286A	SNP	286	286	T	308	308	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T299G	SNP	299	299	T	321	321	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T302G	SNP	302	302	T	324	324	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	322	95.03	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.1	360	0.0	0	.	n	.	0	T306G	SNP	306	306	T	328	328	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	C2194T	SNP	2194	2194	C	74	74	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	G2301A	SNP	2301	2301	G	181	181	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	C2346T	SNP	2346	2346	C	226	226	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2347C	SNP	2347	2347	A	227	227	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	T2358G	SNP	2358	2358	T	238	238	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2361G	SNP	2361	2361	A	241	241	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	T2362C	SNP	2362	2362	T	242	242	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2399G	SNP	2399	2399	A	279	279	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	C2402T	SNP	2402	2402	C	282	282	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	G2408C	SNP	2408	2408	G	288	288	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	T2418A	SNP	2418	2418	T	299	299	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	C2427T	SNP	2427	2427	C	308	308	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	C2429G	SNP	2429	2429	C	310	310	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2526G	SNP	2526	2526	A	407	407	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	417	417	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	474	474	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2895G	SNP	2895	2895	A	776	776	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	T2896C	SNP	2896	2896	T	777	777	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	T2906C	SNP	2906	2906	T	787	787	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	790	790	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2915G	SNP	2915	2915	A	796	796	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	G2920C	SNP	2920	2920	G	801	801	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	821	821	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	871	96.9	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.2	872	0.0	1	SNP	n	A2268C	0	.	.	2268	2268	A	148	148	A	ND	ND	ND	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159:0:0:A2268C:.:b'Point mutation in the 23S rRNA of Mycobaccterium avium shown to confer resistance to azithromycin, a macrolide type antibiotic.'	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T8C	SNP	8	8	T	348	348	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T352C	SNP	352	352	T	14	14	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T433G	SNP	433	433	T	95	95	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	A439G	SNP	439	439	A	101	101	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T443A	SNP	443	443	T	105	105	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T480C	SNP	480	480	T	142	142	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T491C	SNP	491	491	T	153	153	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T521C	SNP	521	521	T	183	183	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	768	140	Mycobacterium_intracellulare_23S_1	3103	334	96.73	Mycobacterium_intracellulare_23S_1.l6.c4.ctg.3	411	0.0	0	.	n	.	0	T589G	SNP	589	589	T	251	251	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	96	96	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	C2563T	SNP	2563	2563	C	123	123	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	153	153	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	T2609C	SNP	2609	2609	T	169	169	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	T2611C	SNP	2611	2611	T	171	171	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	G2841A	SNP	2841	2841	G	401	401	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	A2892G	SNP	2892	2892	A	452	452	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	469	469	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	T2931C	SNP	2931	2931	T	491	491	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	500	500	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	C2991T	SNP	2991	2991	C	551	551	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	598	598	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	C3044T	SNP	3044	3044	C	604	604	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	627	627	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	A3071T	SNP	3071	3071	A	631	631	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	643	643	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	669	97.31	Mycobacterium_kansasii_23S.l15.c4.ctg.1	777	0.0	0	.	n	.	0	C3103.	DEL	3103	3103	C	662	662	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	255	97.65	Mycobacterium_kansasii_23S.l15.c4.ctg.2	348	0.0	0	.	n	.	0	A74T	SNP	74	74	A	167	167	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	255	97.65	Mycobacterium_kansasii_23S.l15.c4.ctg.2	348	0.0	0	.	n	.	0	T149C	SNP	149	149	T	242	242	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	255	97.65	Mycobacterium_kansasii_23S.l15.c4.ctg.2	348	0.0	0	.	n	.	0	A220G	SNP	220	220	A	313	313	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	255	97.65	Mycobacterium_kansasii_23S.l15.c4.ctg.2	348	0.0	0	.	n	.	0	A231T	SNP	231	231	A	324	324	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	255	97.65	Mycobacterium_kansasii_23S.l15.c4.ctg.2	348	0.0	0	.	n	.	0	T241C	SNP	241	241	T	334	334	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	330	99.09	Mycobacterium_kansasii_23S.l15.c4.ctg.3	330	0.0	0	.	n	.	0	G2300A	SNP	2300	2300	G	248	248	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	330	99.09	Mycobacterium_kansasii_23S.l15.c4.ctg.3	330	0.0	0	.	n	.	0	A2347G	SNP	2347	2347	A	295	295	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	330	99.09	Mycobacterium_kansasii_23S.l15.c4.ctg.3	330	0.0	0	.	n	.	0	T2361C	SNP	2361	2361	T	309	309	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	142	Mycobacterium_kansasii_23S	3118	330	99.09	Mycobacterium_kansasii_23S.l15.c4.ctg.3	330	0.0	1	SNP	n	A2265U	0	.	.	2265	2265	A	213	213	A	ND	ND	ND	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178:0:0:A2265U:.:b'Point mutation in the 23S rRNA of Mycobacterium kansasii shown to confer resistance to clarithromycin, a macrolide type antibiotic.'	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	531	274	Mycobacterium_tuberculosis_16S_4	1537	1537	99.93	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.1	2028	0.0	0	.	n	.	0	T90C	SNP	90	90	T	348	348	C	ND	ND	ND	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	531	274	Mycobacterium_tuberculosis_16S_4	1537	1537	99.93	Mycobacterium_tuberculosis_16S_4.l15.c4.ctg.1	2028	0.0	1	SNP	n	A1401G	0	.	.	1401	1401	A	1659	1659	A	ND	ND	ND	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921:0:0:A1401G:.:b"Point mutations in the 3' domain of 16S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin."	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	962	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l15.c4.ctg.1	2057	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	1054	1056	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	962	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l15.c4.ctg.1	2057	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1273	1275	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	417	419	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	432	434	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	528	530	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	708	710	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	1182	1184	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1278	1280	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1317	1319	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1130	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c30.ctg.1	1902	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1395	1397	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	84	100.0	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.1	239	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	44	44	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	169	95.91	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	334	0.0	0	.	n	.	0	C69T	SNP	69	69	C	233	233	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	169	95.91	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	334	0.0	0	.	n	.	0	.75A	INS	75	75	G	240	240	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	169	95.91	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	334	0.0	0	.	n	.	0	T78C	SNP	78	78	T	243	243	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	169	95.91	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.2	334	0.0	0	.	n	.	0	T129C	SNP	129	129	T	294	294	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T975C	SNP	975	975	T	20	20	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	C977T	SNP	977	977	C	22	22	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	A990G	SNP	990	990	A	35	35	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1086C	SNP	1086	1086	T	131	131	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	G1098A	SNP	1098	1098	G	143	143	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	G1099C	SNP	1099	1099	G	144	144	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	C1107T	SNP	1107	1107	C	152	152	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	G1119A	SNP	1119	1119	G	164	164	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	A1211G	SNP	1211	1211	A	256	256	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	G1217A	SNP	1217	1217	G	262	262	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	A1228T	SNP	1228	1228	A	273	273	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1233C	SNP	1233	1233	T	278	278	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	A1234G	SNP	1234	1234	A	279	279	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	G1239T	SNP	1239	1239	G	284	284	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	G1240A	SNP	1240	1240	G	285	285	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	C1250T	SNP	1250	1250	C	295	295	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1252A	SNP	1252	1252	T	297	297	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1258C	SNP	1258	1258	T	303	303	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1274C	SNP	1274	1274	T	319	319	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	A1295G	SNP	1295	1295	A	340	340	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1419C	SNP	1419	1419	T	464	464	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	0	.	n	.	0	T1420G	SNP	1420	1420	T	465	465	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	1	SNP	n	A1375G	0	.	.	1375	1375	A	420	420	A	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:A1375G:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	1	SNP	n	C1376U	0	.	.	1376	1376	C	421	421	C	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:C1376U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	772	184	Mycobacteroides_abscessus_16S_4	1504	549	94.89	Mycobacteroides_abscessus_16S_4.l6.c4.ctg.3	698	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	503	503	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	C1065T	SNP	1065	1065	C	56	56	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	T1066C	SNP	1066	1066	T	57	57	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	G1079C	SNP	1079	1079	G	70	70	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	C1086G	SNP	1086	1086	C	77	77	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	C1087T	SNP	1087	1087	C	78	78	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	A1098G	SNP	1098	1098	A	89	89	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	G1099A	SNP	1099	1099	G	90	90	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	A1191G	SNP	1191	1191	A	182	182	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	G1197A	SNP	1197	1197	G	188	188	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	A1208T	SNP	1208	1208	A	199	199	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	A1214G	SNP	1214	1214	A	205	205	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	G1220A	SNP	1220	1220	G	211	211	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	C1230T	SNP	1230	1230	C	221	221	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	T1232A	SNP	1232	1232	T	223	223	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	T1238C	SNP	1238	1238	T	229	229	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	T1254C	SNP	1254	1254	T	245	245	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	A1275G	SNP	1275	1275	A	266	266	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	T1397C	SNP	1397	1397	T	388	388	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	0	.	n	.	0	T1400G	SNP	1400	1400	T	391	391	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	432	94.91	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.1	624	0.0	1	SNP	n	A1355G	0	.	.	1355	1355	A	346	346	A	ND	ND	ND	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271:0:0:A1355G:.:b'Point mutations in the 16S rRNA of Mycobacteroides chelonae can cause resistance to neomycin.'	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	.47T	INS	47	47	G	231	231	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	C49T	SNP	49	49	C	233	233	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	G57A	SNP	57	57	G	242	242	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	T58C	SNP	58	58	T	243	243	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	C108T	SNP	108	108	C	293	293	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	T109C	SNP	109	109	T	294	294	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	A153G	SNP	153	153	A	338	338	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	C156A	SNP	156	156	C	341	341	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	T158G	SNP	158	158	T	343	343	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	G165T	SNP	165	165	G	350	350	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	A166T	SNP	166	166	A	351	351	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	C173G	SNP	173	173	C	358	358	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	.176GC	INS	176	176	A	362	362	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	160	Mycobacteroides_chelonae_16S_4	1441	197	90.05	Mycobacteroides_chelonae_16S_4.l6.c4.ctg.2	384	0.0	0	.	n	.	0	T182A	SNP	182	182	T	369	369	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2094A	SNP	2094	2094	C	24	24	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2095A	SNP	2095	2095	G	25	25	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2318A	SNP	2318	2318	G	248	248	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2321T	SNP	2321	2321	C	251	251	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A2325G	SNP	2325	2325	A	255	255	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	.2358A	INS	2358	2358	A	289	289	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2360C	SNP	2360	2360	G	291	291	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A2364.	DEL	2364	2364	A	294	294	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2365G	SNP	2365	2365	C	295	295	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2375G	SNP	2375	2375	T	305	305	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2379C	SNP	2379	2379	T	309	309	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2418A	SNP	2418	2418	C	348	348	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2429A	SNP	2429	2429	G	359	359	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2433C	SNP	2433	2433	G	363	363	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2436A	SNP	2436	2436	T	366	366	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2440G	SNP	2440	2440	C	370	370	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2445T	SNP	2445	2445	C	375	375	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2461C	SNP	2461	2461	T	391	391	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2544G	SNP	2544	2544	T	474	474	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2545C	SNP	2545	2545	T	475	475	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2554A	SNP	2554	2554	G	484	484	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2582T	SNP	2582	2582	G	512	512	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2586A	SNP	2586	2586	T	516	516	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2590A	SNP	2590	2590	G	520	520	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C2611T	SNP	2611	2611	C	541	541	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2627C	SNP	2627	2627	T	557	557	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2629C	SNP	2629	2629	T	559	559	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2859A	SNP	2859	2859	G	789	789	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A2913G	SNP	2913	2913	A	843	843	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2914C	SNP	2914	2914	T	844	844	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A2927G	SNP	2927	2927	A	857	857	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G2938C	SNP	2938	2938	G	868	868	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A2958T	SNP	2958	2958	A	888	888	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T2996C	SNP	2996	2996	T	926	926	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C3004T	SNP	3004	3004	C	934	934	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C3009T	SNP	3009	3009	C	939	939	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T3019A	SNP	3019	3019	T	949	949	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A3022T	SNP	3022	3022	A	952	952	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A3025T	SNP	3025	3025	A	955	955	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C3046A	SNP	3046	3046	C	976	976	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A3053T	SNP	3053	3053	A	983	983	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	G3056A	SNP	3056	3056	G	986	986	A	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C3062T	SNP	3062	3062	C	992	992	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	T3077C	SNP	3077	3077	T	1007	1007	C	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A3084G	SNP	3084	3084	A	1014	1014	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	C3089T	SNP	3089	3089	C	1019	1019	T	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	0	.	n	.	0	A3101G	SNP	3101	3101	A	1031	1031	G	ND	ND	ND	.	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161	0	0	528	72	Mycolicibacterium_smegmatis_23S	3162	1058	94.62	Mycolicibacterium_smegmatis_23S.l6.c4.ctg.1	1139	0.0	1	SNP	n	A2267G	0	.	.	2267	2267	A	197	197	A	ND	ND	ND	Mycolicibacterium_smegmatis_23S.3004169.AB011184.1.0_3162.4161:0:0:A2267G:.:b'Point mutation in the 23S rRNA of Mycolicibacterium smegmatis shown to confer resistance to clarithromycin, a macrolide type antibiotic.'	Mycolicibacterium smegmatis 23S rRNA with mutation conferring resistance to clarithromycin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	836	blaC	924	924	100.0	blaC.l15.c30.ctg.1	1391	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	blaC;b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.'
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	539	1326	efpA	1593	1593	99.87	efpA.l15.c30.ctg.1	2168	0.0	0	.	p	.	0	T15R	NONSYN	43	45	ACA	178	180	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	b'efpA is an MFS transporter found in Mycobacterium tuberculosis.';efpA
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	278	280	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	281	283	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	869	871	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1229	1231	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1316	1318	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1652	1654	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2765	2767	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	2172	embA	3285	3285	99.97	embA.l15.c4.ctg.1	3730	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	3005	3007	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003325.BX248333.1.4182808_4186105.3355	embB.3003325.BX248333.1.4182808_4186105.3355	1	1	539	2558	embB	3297	3297	99.97	embB.l15.c30.ctg.1	3598	0.0	0	.	p	.	0	R741W	NONSYN	2221	2223	CGG	2413	2415	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol
embB.3003325.BX248333.1.4182808_4186105.3355	embB.3003325.BX248333.1.4182808_4186105.3355	1	1	539	2558	embB	3297	3297	99.97	embB.l15.c30.ctg.1	3598	0.0	1	SNP	p	T610K	0	.	.	1828	1830	ACG	2020	2022	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003325.BX248333.1.4182808_4186105.3355:1:1:T610K:.:b'Point mutations that occur within Mycobacterium tuberculosis variant bovis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol
embB.3003325.BX248333.1.4182808_4186105.3355	embB.3003325.BX248333.1.4182808_4186105.3355	1	1	539	2558	embB	3297	3297	99.97	embB.l15.c30.ctg.1	3598	0.0	1	SNP	p	Q998R	0	.	.	2992	2994	CAG	3184	3186	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003325.BX248333.1.4182808_4186105.3355:1:1:Q998R:.:b'Point mutations that occur within Mycobacterium tuberculosis variant bovis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol
embB.3003325.BX248333.1.4182808_4186105.3355	embB.3003325.BX248333.1.4182808_4186105.3355	1	1	539	2558	embB	3297	3297	99.97	embB.l15.c30.ctg.1	3598	0.0	1	SNP	p	F1012S	0	.	.	3034	3036	TTC	3226	3228	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003325.BX248333.1.4182808_4186105.3355:1:1:F1012S:.:b'Point mutations that occur within Mycobacterium tuberculosis variant bovis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	T270I	1	T270I	NONSYN	808	810	ACC	1105	1107	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	0	.	p	.	0	R927H	NONSYN	2779	2781	CGC	3076	3078	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	1036	1038	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	1048	1050	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	1057	1059	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1150	1152	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1156	1158	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1159	1161	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1159	1161	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1183	1185	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1183	1185	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1186	1188	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1186	1188	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1195	1197	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1201	1203	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1204	1206	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1216	1218	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1219	1221	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1222	1224	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1225	1227	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1270	1272	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1273	1275	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1276	1278	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1477	1479	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1489	1491	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1768	1770	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1801	1803	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	R738Q	0	.	.	2212	2214	CGG	2509	2511	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	2446	embC	3285	3285	99.88	embC.l15.c4.ctg.1	3859	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3238	3240	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	1044	embR	1167	1167	100.0	embR.l15.c30.ctg.1	1680	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	606	608	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	1044	embR	1167	1167	100.0	embR.l15.c30.ctg.1	1680	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1413	1415	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	0	.	p	.	0	P484S	NONSYN	1450	1452	CCT	1519	1521	TCT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	151	153	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	172	174	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	193	195	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	235	237	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	241	243	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	274	276	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	373	375	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	490	492	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	604	606	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	625	627	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	634	636	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	805	807	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	829	831	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	868	870	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1054	1056	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1090	1092	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1102	1104	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1123	1125	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1183	1185	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1252	1254	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1276	1278	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	539	1440	ethA_2	1470	1470	99.93	ethA_2.l15.c30.ctg.1	1807	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1507	1509	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	405	407	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	465	467	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	465	467	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	474	476	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	474	476	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	474	476	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	492	494	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	492	494	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	513	515	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	618	620	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	795	797	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	795	797	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	804	806	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	804	806	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	894	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2166	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1605	1607	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	298	300	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	319	321	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	343	345	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	343	345	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	349	351	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	352	354	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	355	357	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	373	375	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	409	411	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	418	420	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	421	423	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	433	435	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	445	447	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	445	447	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	460	462	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	460	462	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	E92A	0	.	.	274	276	GAA	484	486	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:E92A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	559	561	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	580	582	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	589	591	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	610	612	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	622	624	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	625	627	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	652	654	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	700	702	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	757	759	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	757	759	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	772	774	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	772	774	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	670	gidB	675	675	99.85	gidB.l15.c17.ctg.1	1116	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	808	810	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	188	190	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	410	412	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	0	.	p	.	0	D639A	NONSYN	1915	1917	GAC	2042	2044	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2129	2131	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	347	349	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	365	367	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	389	391	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	389	391	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	392	394	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	392	394	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	392	394	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	395	397	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	395	397	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	398	400	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	407	409	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	407	409	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	407	409	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	407	409	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	407	409	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	407	409	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1890	gyrA_1	2517	2517	99.72	gyrA_1.l15.c4.ctg.1	3065	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	431	433	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	0	.	p	.	0	A442S	NONSYN	1324	1326	GCG	1637	1639	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1331	1333	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	1811	1813	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	1925	1927	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	1925	1927	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	1928	1930	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	1928	1930	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	1931	1933	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	539	1916	gyrB_6	2145	2145	99.81	gyrB_6.l15.c30.ctg.1	2677	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	1931	1933	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	386	388	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	401	403	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	401	403	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	479	481	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	572	574	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	620	622	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	623	625	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	761	763	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	654	inhA	810	810	100.0	inhA.l15.c30.ctg.1	1493	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	920	922	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	1594	iniA	1923	1923	99.9	iniA.l15.c17.ctg.1	2455	0.0	0	.	p	.	0	N88S	NONSYN	262	264	AAT	535	537	AGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	1594	iniA	1923	1923	99.9	iniA.l15.c17.ctg.1	2455	0.0	0	.	p	.	0	H481Q	NONSYN	1441	1443	CAT	1714	1716	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	1594	iniA	1923	1923	99.9	iniA.l15.c17.ctg.1	2455	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	280	282	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	1594	iniA	1923	1923	99.9	iniA.l15.c17.ctg.1	2455	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1195	1197	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	1594	iniA	1923	1923	99.9	iniA.l15.c17.ctg.1	2455	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1774	1776	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	539	1594	iniA	1923	1923	99.9	iniA.l15.c17.ctg.1	2455	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1882	1884	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	531	702	iniB	1440	1440	99.93	iniB.l15.c4.ctg.1	1925	0.0	0	.	p	.	0	L307fs	FSHIFT	919	919	T	1155	1155	G	ND	ND	ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	531	702	iniB	1440	1440	99.93	iniB.l15.c4.ctg.1	1925	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	376	378	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	1156	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2073	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	467	469	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	1156	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2073	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	962	964	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	752	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1626	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	342	344	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	752	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1626	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	507	509	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	752	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1626	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	951	953	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	752	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1626	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1080	1082	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	752	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1626	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1305	1307	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	752	kasA	1251	1251	99.92	kasA.l15.c4.ctg.1	1626	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1383	1385	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1656	1658	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	366	368	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	540	542	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	597	599	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	600	602	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	642	644	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	645	647	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	648	650	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	693	695	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	708	710	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1059	1061	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1203	1205	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1212	1214	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1212	1214	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1212	1214	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1518	1520	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1650	1652	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1737	1739	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1791	1793	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2088	2090	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1864	katG_1	2223	2223	99.87	katG_1.l15.c4.ctg.1	2832	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2247	2249	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	588	mfpA	552	552	100.0	mfpA.l15.c17.ctg.1	1131	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfpA;b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.'
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	1004	mshA_1	1443	1443	100.0	mshA_1.l15.c17.ctg.1	1782	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1252	1254	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	1228	murA_4	1257	1257	99.92	murA_4.l15.c4.ctg.1	1876	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	616	618	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H57D	1	H57D	NONSYN	169	171	CAC	479	481	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	311	313	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	317	319	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	320	322	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	323	325	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	329	331	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	329	331	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	329	331	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	332	334	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	335	337	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	335	337	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	338	340	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	338	340	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	338	340	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	344	346	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	344	346	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	344	346	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	350	352	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	350	352	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	359	361	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	359	361	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	365	367	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	377	379	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	386	388	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	389	391	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	410	412	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	431	433	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	443	445	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	446	448	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	446	448	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	449	451	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	449	451	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	449	451	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	455	457	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	455	457	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	461	463	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	461	463	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	467	469	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	470	472	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	470	472	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	482	484	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	494	496	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	506	508	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	509	511	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	512	514	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	512	514	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	512	514	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	512	514	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	512	514	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	515	517	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	521	523	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	524	526	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	524	526	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	536	538	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	536	538	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	542	544	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	554	556	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	563	565	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	563	565	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	578	580	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	590	592	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	596	598	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	596	598	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	596	598	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	596	598	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	599	601	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	608	610	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	614	616	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	614	616	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	617	619	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	617	619	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	620	622	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	656	658	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	662	664	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	665	667	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	671	673	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	683	685	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	704	706	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	707	709	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	710	712	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	713	715	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	716	718	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	716	718	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	716	718	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	719	721	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	719	721	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	722	724	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	722	724	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	722	724	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	725	727	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	725	727	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	725	727	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	728	730	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	731	733	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	734	736	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	734	736	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	746	748	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	770	772	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	773	775	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	779	781	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	785	787	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	788	790	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	791	793	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	791	793	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	800	802	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	812	814	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	821	823	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	821	823	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	821	823	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	824	826	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	824	826	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	830	832	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	833	835	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	848	850	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	539	616	pncA	561	561	99.82	pncA.l15.c30.ctg.1	1186	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	854	856	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	614	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1477	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	354	356	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	643	645	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1555	1557	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1720	1722	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1729	1731	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1729	1731	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1729	1731	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1729	1731	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1729	1731	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1738	1740	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1753	1755	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2608	rpoB_1	3519	3519	99.97	rpoB_1.l15.c30.ctg.1	4034	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1783	1785	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	0	.	p	.	0	A440T	NONSYN	1318	1320	GCG	1532	1534	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	581	583	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1184	1186	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1187	1189	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1235	1237	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1238	1240	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1241	1243	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1244	1246	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	539	1206	rpsA	1446	1446	99.93	rpsA.l15.c17.ctg.1	1944	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1265	1267	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	516	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1056	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	398	400	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	516	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1056	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	407	409	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	516	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1056	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	542	544	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	516	rpsL	375	375	100.0	rpsL.l15.c4.ctg.1	1056	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	542	544	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	C949.	DEL	949	949	C	355	355	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	.953T	INS	953	953	C	360	360	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	.959A	INS	959	959	T	367	367	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	G963.	DEL	963	963	G	370	370	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	T1076A	SNP	1076	1076	T	483	483	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	T1207C	SNP	1207	1207	T	614	614	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	G1214A	SNP	1214	1214	G	621	621	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	T1224.	DEL	1224	1224	T	630	630	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	C1227A	SNP	1227	1227	C	633	633	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	G1380A	SNP	1380	1380	G	786	786	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	T1394C	SNP	1394	1394	T	800	800	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	T1396.	DEL	1396	1396	T	801	801	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	0	.	n	.	0	C1406T	SNP	1406	1406	C	811	811	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	128	rrsB_9	1454	861	97.57	rrsB_9.l15.c17.ctg.1	869	0.0	1	SNP	n	C1439U	0	.	.	1439	1439	C	844	844	C	ND	ND	ND	rrsB.3003540.X52922.1.0_1454.4148:0:0:C1439U:.:b'Point mutations in the highly conserved helix 44 of the 16S rrsB rRNA gene of Mycolicibacterium smegmatis can confer resistance to hygromycin B. Resistance against hygromycin B is the result of conformational alterations that distorts a strong hydrogen bond leading to a change in the local geometry of the hygromycin B binding site.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	C990.	DEL	990	990	C	355	355	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	G993T	SNP	993	993	G	358	358	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	.994T	INS	994	994	C	360	360	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	T1002G	SNP	1002	1002	T	369	369	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	G1004.	DEL	1004	1004	G	370	370	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	T1117A	SNP	1117	1117	T	483	483	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	T1248C	SNP	1248	1248	T	614	614	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	G1254T	SNP	1254	1254	G	620	620	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	G1255A	SNP	1255	1255	G	621	621	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	T1265.	DEL	1265	1265	T	630	630	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	C1268A	SNP	1268	1268	C	633	633	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	G1421A	SNP	1421	1421	G	786	786	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	T1437.	DEL	1437	1437	T	801	801	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	0	.	n	.	0	C1447T	SNP	1447	1447	C	811	811	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	1	SNP	n	G1475U	0	.	.	1475	1475	G	839	839	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475U:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	528	200	rrsB_13	1528	894	98.21	rrsB_13.l15.c30.ctg.1	1098	0.0	1	SNP	n	G1475A	0	.	.	1475	1475	G	839	839	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475A:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	495	497	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	537	539	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	654	656	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	660	662	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	678	680	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	702	704	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	732	734	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	744	746	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	807	809	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	885	887	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	912	914	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	1035	1037	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	1050	1052	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	1101	1103	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	660	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1456	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	1134	1136	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	139	141	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	298	300	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	304	306	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	370	372	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	451	453	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	481	483	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	547	549	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	646	648	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	652	654	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	805	807	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	624	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1258	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	811	813	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
